FindTrial
Sign In

A retrospective cohort study of patients with bronchiectasis from study CTR20182034 who were followed up for 52 weeks after treatment with tobramycin inhalation solution

A retrospective cohort study of patients with bronchiectasis from study CTR20182034 who were followed up for 52 weeks after treatment with tobramycin inhalation solution

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069245
Enrollment
Unknown
Registered
2023-03-10
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

Group of bronchiectasis:N/A

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Completed the study during CTR20182034 clinical study, receiving tobramycin inhalation solution or placebo for at least 28 days. 2. Aged >=18 years. 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Complicated with malignant tumor. 2. Participated in other interventional clinical trials within 52 weeks after withdrawal of CTR20182034.

Design outcomes

Primary

MeasureTime frame
Number of acute exacerbations of bronchiectasis per capita;—

Secondary

MeasureTime frame
Proportion of inpatients with acute exacerbation of bronchiectasis;Number of acute exacerbations of bronchiectasis per capita;Cumulative per capita hospitalization days of acute exacerbation of bronchiectasis;Average number of days in a single hospital with acute exacerbation of bronchiectasis;Per capita times of acute exacerbation of bronchiectasis in outpatient/emergency department;Number of people with acute exacerbation of bronchiectasis;Acute exacerbation rate of bronchiectasis;Time of acute exacerbation of first bronchiectasis;QoL-B-RSS Score;—

Countries

China

Contacts

Public ContactGuan Weijie

The First Affiliated Hospital of Guangzhou Medical University

battery203@163.com+86 13826042052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026